Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive OC histotype. Although initially sensitive to standard platinum-based chemotherapy, most HGSOC patients relapse and become chemoresistant. We have previously demonstrated that platinum resistance is driven by a metabolic shif...
Saved in:
Main Authors: | Daniela Criscuolo (Author), Rosario Avolio (Author), Matteo Parri (Author), Simona Romano (Author), Paola Chiarugi (Author), Danilo Swann Matassa (Author), Franca Esposito (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
by: Reem Abdallah, et al.
Published: (2023) -
Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
by: Michelle Greenman, et al.
Published: (2024) -
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019) -
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2020) -
Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer
by: Andriy Rybin
Published: (2018)